Michael Schultz

Principal investigator, leads VIEWPOINT MOLECULAR TARGETING, INC..

BiotechFounder

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2022First federal award

$2.0MFederal grants as PI1 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20222022

AwardsPatents

Federal awards as principal investigator

1 awards · $2.0M

Date	Agency	Award	Amount	Company
Aug 4, 2022	NIH	SBIR Phase II Image-guided dosimetry-based alpha particle therapy for neuroblastoma.	$2.0M	VIEWPOINT MOLECULAR TARGETING, INC.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#1,090

Awards as PI#2,176

Patents#273

From filings, awards and patents

Companies

VIEWPOINT MOLECULAR TARGETING, INC.Leads (SEC Form D) · Biotech

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.